Neovasc device trial for hard-to-treat chest pain
Part of Heart & circulation, Pain clinical trials.
This trial tests a device called the Neovasc Coronary Sinus Reducer to help people with long-lasting, hard-to-control chest pain (angina) who cannot have artery-opening procedures. It may improve symptoms by changing blood flow in the heart’s vein system.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be older than 18 years
- Have ongoing, difficult chest pain from coronary artery disease despite best medications for at least 30 days
- Not be able to get surgery or artery-opening procedures (stent/PCI or bypass/CABG), as decided by doctors
- Have testing that shows parts of the heart may improve with more blood flow (reversible ischemia on stress ultrasound or a similar scan)
- Have avoided recent heart emergencies: no heart attack/unstable angina in the last 3 months and no stent or bypass in the last 6 months
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether a small pressure-reducing device placed in a heart vein (the coronary sinus) can reduce symptoms in people with ongoing chest pain from tiny blood vessel problems. It is for angina that has not improved despite standard heart medicines, and only if special heart tests show reversible reduced blood flow.
This trial tests whether implanting a small device in the heart’s coronary sinus can reduce symptoms in people with long-lasting “refractory” angina despite taking the usual heart medicines. It may help improve how much activity you can do and reduce angina-related limitations.
This trial tests a new gene therapy (XC001) delivered through a thin tube into your heart's blood vessels. It aims to grow new blood vessels to relieve chest pain in people with chronic angina who have no other treatment options.
This trial tests a device called the Coronary Sinus Reducer for people with chest pain caused by problems in the small arteries of the heart. The device is placed in a vein near the heart to improve blood flow and reduce symptoms.
This study tests a device (Coronary Sinus Reducer) for people who still have chest pain despite medications and cannot have standard treatments like stents or bypass. It may help improve blood flow and reduce symptoms.
This study tests a device called the sinus reducer for people with long-lasting chest pain that hasn't improved with medication or other procedures. It may help if you have limited options for treatment.
Hear when a new Refractory Angina trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.